Gutierrez-Sandoval, R.; Gutierrez-Castro, F.; Muñoz-Godoy, N.; Rivadeneira, I.; Sobarzo, A.; Alarcón, L.; Dorado, W.; Lagos, A.; Montenegro, D.; Muñoz, I.;
et al. Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy. Biomedicines 2025, 13, 1299.
https://doi.org/10.3390/biomedicines13061299
AMA Style
Gutierrez-Sandoval R, Gutierrez-Castro F, Muñoz-Godoy N, Rivadeneira I, Sobarzo A, Alarcón L, Dorado W, Lagos A, Montenegro D, Muñoz I,
et al. Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy. Biomedicines. 2025; 13(6):1299.
https://doi.org/10.3390/biomedicines13061299
Chicago/Turabian Style
Gutierrez-Sandoval, Ramon, Francisco Gutierrez-Castro, Natalia Muñoz-Godoy, Ider Rivadeneira, Adolay Sobarzo, Luis Alarcón, Wilson Dorado, Andy Lagos, Diego Montenegro, Ignacio Muñoz,
and et al. 2025. "Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy" Biomedicines 13, no. 6: 1299.
https://doi.org/10.3390/biomedicines13061299
APA Style
Gutierrez-Sandoval, R., Gutierrez-Castro, F., Muñoz-Godoy, N., Rivadeneira, I., Sobarzo, A., Alarcón, L., Dorado, W., Lagos, A., Montenegro, D., Muñoz, I., Aguilera, R., Iturra, J., Krakowiak, F., Peña-Vargas, C., & Toledo, A.
(2025). Phospholipid-Rich DC-Vesicles with Preserved Immune Fingerprints: A Stable and Scalable Platform for Precision Immunotherapy. Biomedicines, 13(6), 1299.
https://doi.org/10.3390/biomedicines13061299
